Home FDA probes cognitive impact of new cholesterol drugs
 

Keywords :   


FDA probes cognitive impact of new cholesterol drugs

2014-03-08 17:04:55| Biotech - Topix.net

T he Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.

Tags: impact drugs cognitive cholesterol

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »